Our data supports this, showing that the decrease in adipose tissue weight and hepatic ER stress markers by DADS supplementation resulted in a clear improvement of hyperleptinemia and hypercholesterolemia in WD-fed ApoE−/− mice. The gene discussed is APOE; the disease is Hypercholesterolemia.